Technical Report Medical Simulation Oncology Substance Use and Addiction
Effect of telemedicine follow-up on glycaemic control among patients with hip fracture

Effect of telemedicine follow-up on glycaemic control among patients with hip fracture

Authors

Mateo Lindqvist

Mateo Lindqvist

Mayo Clinic, Syria

Corresponding
Malik Osei

Malik Osei

Charité Berlin, Bulgaria

Hugo Patel

Hugo Patel

Royal Melbourne Hospital, Zimbabwe

Noura Haddad

Noura Haddad

Cleveland Clinic Abu Dhabi, Somalia

Mateo Ahmed

Mateo Ahmed

Karolinska University Hospital, Tonga

Zainab Herrera

Zainab Herrera

Singapore General Hospital, United States

Published

July 26, 2024

Paper ID

PAP-000239

Status

Published

DOI

10.65712/tmj.test000497

Effect of telemedicine follow-up on glycaemic control among patients with hip fracture

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on telemedicine follow-up. Methods: We conducted a case series across 2 centres between 2017 and 2024. Results: 1001 participants were included (median age 34 years). Serious adverse events were rare and similar between groups. Conclusion: These findings suggest that telemedicine follow-up is associated with better glycaemic control in patients with hip fracture.

Introduction

Earlier studies of telemedicine follow-up were small or single-centre. The cost of glycaemic control to health systems is substantial.

Guidelines make only a weak recommendation on telemedicine follow-up. Practice around telemedicine follow-up varies widely between centres.

Discussion

Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols. These findings suggest that telemedicine follow-up is associated with better glycaemic control in patients with hip fracture.

Future work should test telemedicine follow-up in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.

Future work should test telemedicine follow-up in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.

These findings suggest that telemedicine follow-up is associated with better glycaemic control in patients with hip fracture. Strengths include the sample size and blinded outcome assessment.

Conclusions

Telemedicine follow-up should be considered for patients with hip fracture to improve glycaemic control.

References

1. Nasser T, Mueller P, et al. An enhanced recovery pathway and acute kidney injury. Pediatrics. 2023;344(7):718-1177.

2. Haddad W, Nasser S, et al. Tranexamic acid and emergency department revisits. Pediatrics. 2015;202(8):479-914.

3. Dubois M, Costa G, et al. An antibiotic stewardship programme and medication adherence. Crit Care Med. 2008;95(1):198-1690.

4. Silva B, Ahmed Z, et al. Nurse-led discharge planning and health-related quality of life. Crit Care Med. 2010;324(7):234-1374.

5. Patel Z, Rahman O, et al. Machine-learning triage and length of stay. JAMA. 2013;230(10):577-932.

Appendices

Supplementary tables are available on request.

Materials and Methods

Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients with hip fracture.

Eligible participants were patients with hip fracture. We conducted a case series across 2 centres between 2017 and 2024.

Results

The adjusted odds ratio was 0.86 (95% CI 0.38 to 0.98). Effects were consistent across prespecified subgroups.

The adjusted odds ratio was 0.40 (95% CI 0.27 to 0.70). glycaemic control occurred in 4% of the intervention group versus 27% of controls. Effects were consistent across prespecified subgroups.

The adjusted odds ratio was 0.43 (95% CI 0.39 to 0.96). The adjusted odds ratio was 0.45 (95% CI 0.31 to 0.98).

GroupnEventsRate %OR95% CI
Centre B1441021.10.560.59–1.12
Age ≥ 651392426.30.800.49–1.21
Male1884838.60.780.46–1.34
Centre A6952029.40.720.57–1.38
Age ≥ 6521184.30.400.21–1.5
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in glycaemic control
Shown for patients with hip fracture; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Forest plot of glycaemic control
Shown for patients with hip fracture; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. 301 participants were included (median age 37 years).